


{"id":13873,"date":"2022-05-12T13:41:33","date_gmt":"2022-05-12T17:41:33","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/?page_id=13873"},"modified":"2023-11-10T14:36:04","modified_gmt":"2023-11-10T19:36:04","slug":"representation","status":"publish","type":"page","link":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/","title":{"rendered":"Repr\u00e9sentation"},"content":{"rendered":"\n<div class=\"wp-block-cover alignfull is-light has-custom-content-position is-position-bottom-left hero tall\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim wp-block-cover__gradient-background has-background-gradient\" style=\"background:linear-gradient(360deg,#000000CB 0%,#00000033 100%)\"><\/span><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1280\" class=\"wp-block-cover__image-background wp-image-13647\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg\" style=\"object-position:42% 29%\" data-object-fit=\"cover\" data-object-position=\"42% 29%\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg 1920w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-1024x683.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-1536x1024.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero-800x534.jpg 800w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h1 class=\"wp-block-post-title has-text-color has-white-color\">Repr\u00e9sentation<\/h1>\n\n\n<p class=\"h4 has-white-color has-text-color\">M\u00e9dicaments novateurs Canada repr\u00e9sente l\u2019industrie pharmaceutique novatrice du Canada.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<p id=\"overview\">Nous nous engageons \u00e0 \u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. Nous nous associons entre autres avec des gouvernements, des compagnies d\u2019assurance, des professionnels de la sant\u00e9 et d\u2019autres parties prenantes pour faire progresser le secteur des sciences de la vie de notre pays.<\/p>\n\n\n\n<p>Les alliances fructueuses que nous formons soutiennent les politiques qui am\u00e9liorent l\u2019environnement r\u00e9glementaire du Canada, prot\u00e8gent la propri\u00e9t\u00e9 intellectuelle et \u00e9largissent l\u2019acc\u00e8s aux produits pharmaceutiques les plus r\u00e9cents au Canada. Nous menons toutes nos activit\u00e9s de repr\u00e9sentation pour am\u00e9liorer le bien-\u00eatre de tous les Canadiens et prot\u00e9ger la s\u00e9curit\u00e9 des patients au nom de nos membres<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull has-light-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Partenariat avec le gouvernement<\/h2>\n\n\n\n<p>Les compagnies pharmaceutiques novatrices du Canada investissent plus de 2,2 milliards de dollars par ann\u00e9e pour trouver de nouvelles fa\u00e7ons de traiter et de gu\u00e9rir les maladies.\u00a0Qu\u2019il s\u2019agisse d\u2019apporter une r\u00e9ponse sans pr\u00e9c\u00e9dent \u00e0 une pand\u00e9mie mondiale ou de fournir des traitements salutaires aux patients atteints de cancer, de maladies cardiaques ou de maladies rares, le secteur pharmaceutique novateur du Canada est un partenaire important qui contribue \u00e0 maintenir la population en bonne sant\u00e9, \u00e0 faire cro\u00eetre l\u2019\u00e9conomie et \u00e0 soutenir l\u2019innovation qui permettra de relever les d\u00e9fis actuels et futurs en mati\u00e8re de sant\u00e9.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-1024x683.jpg\" alt=\"\" class=\"wp-image-13645\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-1024x683.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-1536x1025.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1-800x534.jpg 800w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-1024x683.jpg\" alt=\"\" class=\"wp-image-13643\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-1024x683.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-1536x1024.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2-800x534.jpg 800w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-partnering-gov2.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p>Nous repr\u00e9sentons les int\u00e9r\u00eats des gouvernements f\u00e9d\u00e9ral et r\u00e9gionaux, en veillant \u00e0 ce que toutes les voix soient pr\u00e9sentes sur le tableau politique. Les opinions que nous \u00e9mettons et les campagnes de communication que nous utilisons pour atteindre les parties prenantes du secteur des soins de sant\u00e9 sont \u00e9tay\u00e9es par des donn\u00e9es et nos recherches, ou encore par celles de nos prestataires de confiance.<\/p>\n\n\n\n<p>\u00c0 l\u2019heure actuelle, le Canada attire environ 1&nbsp;% des investissements mondiaux en recherche et d\u00e9veloppement pharmaceutiques. Nous pouvons faire beaucoup mieux. Nous travaillons avec l\u2019industrie et les gouvernements pour cr\u00e9er un environnement r\u00e9glementaire comparable \u00e0 celui du reste du monde. Notre objectif est d\u2019attirer un plus grand nombre d\u2019investissements \u00e9trangers et d\u2019essais cliniques.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Protection de la propri\u00e9t\u00e9 intellectuelle<\/h2>\n\n\n\n<div class=\"wp-block-baytek-tabs has-white-background-color has-background wp-block-tabs has-vertical-orientation\"><div class=\"wp-block-tabs__inner-container\"><div class=\"wp-block-tabs__tab-labels\"><a class=\"tab-label active\" role=\"tab\" data-target=\"0\"><span>Aper\u00e7u<\/span><\/a><a class=\"tab-label\" role=\"tab\" data-target=\"1\"><span>Accord \u00e9conomique et commercial global<\/span><\/a><a class=\"tab-label\" role=\"tab\" data-target=\"2\"><span>Accord Canada\u2013\u00c9tats-Unis\u2013Mexique<\/span><\/a><\/div><div class=\"wp-block-tabs__tab-panels\">\n<div class=\"wp-block-tab\">\n<p>Un environnement de propri\u00e9t\u00e9 intellectuelle concurrentiel \u00e0 l\u2019\u00e9chelle mondiale est crucial pour faire progresser l\u2019innovation dans n\u2019importe quelle industrie. Nous travaillons avec diligence pour prot\u00e9ger l\u2019innovation des produits pharmaceutiques fond\u00e9s sur des donn\u00e9es probantes en faisant progresser&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>une <em>Loi sur les brevets<\/em> qui pr\u00e9voit des protections et des mesures incitatives comparables \u00e0 celles des autres pays d\u00e9velopp\u00e9s, et qui est interpr\u00e9t\u00e9e et appliqu\u00e9e d\u2019une mani\u00e8re qui respecte les normes internationales, telles que le brevet d\u2019utilit\u00e9;<\/li>\n\n\n\n<li>un <em>R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s <\/em>\u00e9quilibr\u00e9, pr\u00e9visible et \u00e9quitable pour les innovateurs;<\/li>\n\n\n\n<li>un r\u00e8glement sur la protection des donn\u00e9es qui prot\u00e8ge l\u2019exclusivit\u00e9 de tous les m\u00e9dicaments novateurs;<\/li>\n\n\n\n<li>un <em>R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s<\/em> qui assigne un mandat clair et limit\u00e9 au Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB), et une d\u00e9finition mise \u00e0 jour permettant de calculer avec pr\u00e9cision les investissements de l\u2019industrie au Canada.<\/li>\n<\/ul>\n<\/div>\n\n\n\n<div class=\"wp-block-tab\">\n<p>En 2013, le gouvernement f\u00e9d\u00e9ral a pris des mesures pour am\u00e9liorer la protection de la propri\u00e9t\u00e9 intellectuelle au Canada en ratifiant l\u2019accord \u00e9conomique et commercial global (AECG). Cet accord historique a constitu\u00e9 une \u00e9tape essentielle pour renforcer la position du Canada sur la sc\u00e8ne internationale dans le domaine des sciences de la vie.<\/p>\n\n\n\n<p>L\u2019AECG a apport\u00e9 plusieurs am\u00e9liorations essentielles \u00e0 la protection de la propri\u00e9t\u00e9 intellectuelle, notamment les suivantes&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Le r\u00e9tablissement de la dur\u00e9e des brevets (RDB)<\/strong>, qui permet aux compagnies de recherche pharmaceutique de r\u00e9cup\u00e9rer jusqu\u2019\u00e0 deux ans de temps perdu sur leur brevet en raison des longs processus r\u00e9glementaires et d\u2019approbation gouvernementale. L\u2019indemnisation est assur\u00e9e par un certificat de protection suppl\u00e9mentaire (CPS). La possibilit\u00e9 de recevoir un CPS n\u2019est pas absolue et est soumise \u00e0 un certain nombre d\u2019exemptions pr\u00e9vues par la Loi. Le Canada \u00e9tait auparavant le seul pays du G7 \u00e0 ne pr\u00e9voir aucune forme de RDB;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Le droit d\u2019appel<\/strong>, qui permet aux compagnies de recherche pharmaceutique de faire appel plus efficacement des d\u00e9cisions o\u00f9 un brevet est jug\u00e9 invalide. Auparavant, le processus d\u2019appel \u00e9tait accessible aux contestataires, mais pas aux propri\u00e9taires de brevets;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Le R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s (avis de conformit\u00e9)<\/strong>, qui permet de prot\u00e9ger les titulaires de brevets lorsque les compagnies de m\u00e9dicaments g\u00e9n\u00e9riques enfreignent leurs droits en entrant trop t\u00f4t sur le march\u00e9. Le r\u00e8glement emp\u00eache ces compagnies d\u2019obtenir un avis de conformit\u00e9 pendant une p\u00e9riode pouvant aller jusqu\u2019\u00e0 24&nbsp;mois au cours d\u2019un litige.<\/li>\n<\/ul>\n<\/div>\n\n\n\n<div class=\"wp-block-tab\">\n<p>La ren\u00e9gociation de l\u2019Accord de libre-\u00e9change nord-am\u00e9ricain (ALENA) a offert une excellente occasion d\u2019am\u00e9liorer le r\u00e9gime de propri\u00e9t\u00e9 intellectuelle du Canada. Le texte original de l\u2019ACEUM a connu des am\u00e9liorations substantielles. Cependant, le texte final n\u2019am\u00e9liore pas le r\u00e9gime de propri\u00e9t\u00e9 intellectuelle du Canada autant qu\u2019il le pourrait. \u00c0 l\u2019origine, l\u2019accord offrait aux compagnies de recherche pharmaceutique dix ans de protection des donn\u00e9es pour les nouveaux m\u00e9dicaments biologiques, mais cette am\u00e9lioration a \u00e9t\u00e9 retir\u00e9e de l\u2019accord ratifi\u00e9.<\/p>\n\n\n\n<p>Malgr\u00e9 l\u2019absence de protection des donn\u00e9es pour les nouveaux m\u00e9dicaments biologiques, l\u2019ACEUM offre la possibilit\u00e9 d\u2019am\u00e9liorer de fa\u00e7on significative le r\u00e9gime de propri\u00e9t\u00e9 intellectuelle du Canada. L\u2019ajustement de la dur\u00e9e des brevets (ADB) fournira une protection suppl\u00e9mentaire des donn\u00e9es dans le cas o\u00f9 les titulaires de brevet subissent des retards d\u00e9raisonnables dans le processus d\u2019examen de ceux-ci. Le gouvernement du Canada ne s\u2019est pas encore acquitt\u00e9 de son obligation de modifier sa <em>Loi sur les brevets<\/em>, bien qu\u2019il doive le faire d\u2019ici le 1<sup>er<\/sup>&nbsp;janvier&nbsp;2025.<\/p>\n\n\n\n<p>Pour plus de renseignements sur le r\u00e9gime de propri\u00e9t\u00e9 intellectuelle du Canada et pour le comparer avec celui d\u2019autres gouvernements, consultez les ressources ci-dessous.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.theglobalipcenter.com\/wp-content\/uploads\/2021\/03\/GIPC_IPIndex2021_FullReport_v3.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">L\u2019indice international de la propri\u00e9t\u00e9 intellectuelle&nbsp;2021 du Global Innovation Policy Center<\/a> (en anglais seulement)<br \/><a href=\"https:\/\/ustr.gov\/sites\/default\/files\/files\/reports\/2021\/2021%20Special%20301%20Report%20(final).pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Rapport sp\u00e9cial&nbsp;301 de 2021 du U.S. Trade Representative<\/a> (en anglais seulement)<\/p>\n<\/div>\n<\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-image-fill has-light-grey-background-color has-background\"><div class=\"wp-block-media-text__content\">\n<h2 class=\"wp-block-heading\">Am\u00e9liorer l\u2019acc\u00e8s au Canada<\/h2>\n\n\n\n<p>L\u2019am\u00e9lioration de l\u2019acc\u00e8s des patients canadiens aux m\u00e9dicaments, vaccins et traitements novateurs est au c\u0153ur de notre travail. Nous nous engageons \u00e0 travailler en collaboration avec les gouvernements, l\u2019industrie, les professionnels de la sant\u00e9 et d\u2019autres parties prenantes cl\u00e9s afin d\u2019am\u00e9liorer le processus de tarification et de remboursement, et de garantir aux Canadiens un acc\u00e8s rapide aux nouveaux m\u00e9dicaments.<\/p>\n\n\n\n<p>Aujourd\u2019hui, les Canadiens couverts par un r\u00e9gime public d\u2019assurance m\u00e9dicaments attendent en moyenne 22&nbsp;mois apr\u00e8s l\u2019approbation de Sant\u00e9&nbsp;Canada pour avoir acc\u00e8s \u00e0 de nouveaux m\u00e9dicaments. Il s\u2019agit d\u2019un d\u00e9lai deux fois plus long que dans la plupart des autres pays de l\u2019Organisation de coop\u00e9ration et de d\u00e9veloppement \u00e9conomiques (OCDE). Le Canada se classe ainsi au 19<sup>e<\/sup>&nbsp;rang sur 20&nbsp;pays dot\u00e9s d\u2019un statut \u00e9conomique similaire.<\/p>\n\n\n\n<p>En simplifiant la voie d\u2019acc\u00e8s, nous pouvons donner aux Canadiens un acc\u00e8s plus rapide aux meilleures innovations que l\u2019industrie puisse offrir et, ce faisant, obtenir de meilleurs r\u00e9sultats pour la sant\u00e9 de tous.<strong><\/strong><\/p>\n<\/div><figure class=\"wp-block-media-text__media\" style=\"background-image:url(https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-1024x683.jpg);background-position:50% 50%\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-1024x683.jpg\" alt=\"\" class=\"wp-image-13663 size-full\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-1024x683.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-1536x1024.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access-800x534.jpg 800w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-expanding-access.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div id=\"policy-positions\" class=\"wp-block-group theme-cyan featured-section no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading is-style-eyebrow\">\u00c9nonc\u00e9s de position<\/h2>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group featured-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"empty-feature-wrapper\">\n\t<p>D\u00e9sol\u00e9, aucun message n\u2019a \u00e9t\u00e9 trouv\u00e9. Veuillez rev\u00e9rifier plus tard.<\/p>\n<\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color has-text-color wp-element-button\" href=\"\/resources\/all-resources\/?resource-category=policy-positions\">View all<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-padded no-margin has-light-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div id=\"government-submissions\" class=\"wp-block-group theme-green featured-section no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading is-style-eyebrow\">M\u00e9moires pour le gouvernement<\/h2>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group featured-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/soumission-pour-les-consultations-parlementaires-sur-le-projet-de-loi-15-loi-visant-a-rendre-le-systeme-de-sante-et-de-services-sociaux-plus-efficace\/\" aria-label=\"Soumission pour les consultations parlementaires sur le projet de loi 15, Loi visant \u00e0 rendre le syst\u00e8me de sant\u00e9 et de services sociaux plus efficace\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1-pdf-232x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1-pdf-232x300.jpg 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1-pdf-791x1024.jpg 791w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1-pdf-116x150.jpg 116w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1-pdf.jpg 1088w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n                            <span class=\"date\" itemprop=\"datePublished\">08 juin 2023<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/soumission-pour-les-consultations-parlementaires-sur-le-projet-de-loi-15-loi-visant-a-rendre-le-systeme-de-sante-et-de-services-sociaux-plus-efficace\/\">Soumission pour les consultations parlementaires sur le projet de loi 15, Loi visant \u00e0 rendre le syst\u00e8me de sant\u00e9 et de services sociaux plus efficace<\/a><\/h3>\t\t\t\n\t\t\t\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/soumission-pour-les-consultations-parlementaires-sur-le-projet-de-loi-15-loi-visant-a-rendre-le-systeme-de-sante-et-de-services-sociaux-plus-efficace\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/06\/6377_IMC_QOT-Bill15-Submission_fre_v1.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content -->\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color has-text-color wp-element-button\" href=\"\/resources\/all-resources\/?resource-category=submission-papers\">View all<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group theme-yellow is-padded no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns alignfull is-not-stacked-on-mobile\">\n\t<div class=\"wp-block-column\">\n\t\t<p class=\"is-style-eyebrow\">Domaines d'activit\u00e9<\/p>\n\t<\/div>\n\n\t<div class=\"wp-block-column topic-slider-control\"><\/div>\n<\/div>\n\n<section class=\"topics-slider slides-3\" data-slides=\"3\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/regimes-prives-dassurance-medicaments\/\" class=\"wp-block-cover slide\" aria-label=\"R\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/browse-by-private-drug-coverage-hero-1024x683.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">R\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/fondation-pour-la-recherche-en-sante\/\" class=\"wp-block-cover slide\" aria-label=\"Fondation pour la recherche en sant\u00e9\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/browse-by-hrf-hero-1024x683.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">Fondation pour la recherche en sant\u00e9<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/acces-aux-medicaments\/\" class=\"wp-block-cover slide\" aria-label=\"Acc\u00e8s aux m\u00e9dicaments\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/access-to-medicine-hero-1024x683.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">Acc\u00e8s aux m\u00e9dicaments<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb\/\" class=\"wp-block-cover slide\" aria-label=\"Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero-1024x683.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/advocacy\/pharmacare\/\" class=\"wp-block-cover slide\" aria-label=\"Pharmacare\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/browse-by-pharmacare-hero-1024x723.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">Pharmacare<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/parcourir-par\/medicaments-pour-les-maladies-rares\/\" class=\"wp-block-cover slide\" aria-label=\"M\u00e9dicaments pour les maladies rares\">\n\t\t\t<span aria-hidden=\"true\" class=\"wp-block-cover__gradient-background has-background-dim has-background-gradient\"><\/span>\n\n\t\t\t<img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/browse-by-drd-herp-1024x683.jpg\"\/>\n\n\t\t\t<div class=\"wp-block-cover__inner-container\">\n\t\t\t\t<h2 class=\"topic-title has-white-color h5\">M\u00e9dicaments pour les maladies rares<\/h2>\n\t\t\t<\/div>\n\t\t<\/a>\n\t<\/section>\n\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-padded no-margin has-light-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div id=\"statements-press-releases\" class=\"wp-block-group theme-coral featured-section no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading is-style-eyebrow\">communiqu\u00e9s de presse<\/h2>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group featured-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-medicaments-novateurs-canada-au-sujet-du-projet-de-loi-sur-lassurance-medicaments\/\" aria-label=\"D\u00e9claration de M\u00e9dicaments novateurs Canada au sujet du projet de loi sur l\u2019assurance m\u00e9dicaments\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"200\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/02\/pharmacare-statement-photo-for-web-300x200.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/02\/pharmacare-statement-photo-for-web-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/02\/pharmacare-statement-photo-for-web-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/02\/pharmacare-statement-photo-for-web-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/02\/pharmacare-statement-photo-for-web.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Assurance m\u00e9dicaments<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">29 f\u00e9vrier 2024<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-medicaments-novateurs-canada-au-sujet-du-projet-de-loi-sur-lassurance-medicaments\/\">D\u00e9claration de M\u00e9dicaments novateurs Canada au sujet du projet de loi sur l\u2019assurance m\u00e9dicaments<\/a><\/h3>\t\t\t\n\t\t\t<p>Ottawa, 29 f\u00e9vrier 2024 \u2013 M\u00e9dicaments novateurs Canada (MNC) s\u2019inqui\u00e8te de l\u2019intention du gouvernement f\u00e9d\u00e9ral dans le projet de loi [&hellip;]<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-medicaments-novateurs-canada-au-sujet-du-projet-de-loi-sur-lassurance-medicaments\/\">En savoir plus<\/a>\n                            <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-mnc-sur-la-decision-de-la-fda-dautoriser-la-floride-a-importer-des-medicaments-du-canada\/\" aria-label=\"D\u00e9claration de MNC sur la d\u00e9cision de la FDA d\u2019autoriser la Floride \u00e0 importer des m\u00e9dicaments du Canada\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"225\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-300x225.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-300x225.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-1024x767.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-768x575.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-1536x1150.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-744x557.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2024\/01\/iStock-1201265321-1-scaled.jpg 1980w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Acc\u00e8s aux m\u00e9dicaments<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">05 janvier 2024<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-mnc-sur-la-decision-de-la-fda-dautoriser-la-floride-a-importer-des-medicaments-du-canada\/\">D\u00e9claration de MNC sur la d\u00e9cision de la FDA d\u2019autoriser la Floride \u00e0 importer des m\u00e9dicaments du Canada<\/a><\/h3>\t\t\t\n\t\t\t<p>Ottawa, le 5&nbsp;janvier&nbsp;2024.&nbsp;\u2013 M\u00e9dicaments novateurs Canada (MNC) est tr\u00e8s pr\u00e9occup\u00e9e par la d\u00e9cision de la Food and Drug Administration (FDA) [&hellip;]<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/declaration-de-mnc-sur-la-decision-de-la-fda-dautoriser-la-floride-a-importer-des-medicaments-du-canada\/\">En savoir plus<\/a>\n                            <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-une-bourse-detudes-pour-le-programme-une-seule-sante-de-luniversite-de-guelph\/\" aria-label=\"M\u00e9dicaments novateurs Canada annonce une bourse d\u2019\u00e9tudes pour le programme Une seule sant\u00e9 de l\u2019Universit\u00e9 de Guelph\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"210\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/11\/ovc-horse-300x210.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/11\/ovc-horse-300x210.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/11\/ovc-horse-768x538.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/11\/ovc-horse-744x521.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/11\/ovc-horse.jpg 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n                            <span class=\"date\" itemprop=\"datePublished\">16 novembre 2023<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-une-bourse-detudes-pour-le-programme-une-seule-sante-de-luniversite-de-guelph\/\">M\u00e9dicaments novateurs Canada annonce une bourse d\u2019\u00e9tudes pour le programme Une seule sant\u00e9 de l\u2019Universit\u00e9 de Guelph<\/a><\/h3>\t\t\t\n\t\t\t<p>Ottawa, le 16&nbsp;novembre&nbsp;2023.&nbsp;\u2013 M\u00e9dicaments novateurs Canada (MNC) a le plaisir d\u2019annoncer l\u2019octroi d\u2019une bourse de 25&nbsp;000&nbsp;$ au programme de baccalaur\u00e9at [&hellip;]<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-une-bourse-detudes-pour-le-programme-une-seule-sante-de-luniversite-de-guelph\/\">En savoir plus<\/a>\n                            <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content -->\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color has-text-color wp-element-button\" href=\"\/resources\/all-resources\/?resource-category=submission-papers\">View all<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-padded no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div id=\"analysis-reports\" class=\"wp-block-group theme-teal featured-section no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading is-style-eyebrow\">Analyses et rapports<\/h2>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group featured-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/analyse-des-generateurs-de-couts-2023\/\" aria-label=\"Analyse des g\u00e9n\u00e9rateurs de co\u00fbts 2023\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-232x300.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-232x300.png 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-791x1024.png 791w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-768x994.png 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-1187x1536.png 1187w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20-445x576.png 445w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/10\/CostDriver2023_FRE_v20.png 1275w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Acc\u00e8s aux m\u00e9dicaments<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">19 octobre 2023<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/analyse-des-generateurs-de-couts-2023\/\">Analyse des g\u00e9n\u00e9rateurs de co\u00fbts 2023<\/a><\/h3>\t\t\t\n\t\t\t<p>La croissance annuelle des co\u00fbts sur le march\u00e9 des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments au Canada est attribuable \u00e0 une utilisation accrue des m\u00e9dicaments et aux m\u00e9dicaments pour les maladies chroniques, ainsi qu\u2019\u00e0 une augmentation du nombre de r\u00e9clamants depuis la pand\u00e9mie.<br \/>\nLire le rapport complet.<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/analyse-des-generateurs-de-couts-2023\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/12\/CostDriver2023_FRE_v21.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/la-valeur-des-medicaments-au-canada\/\" aria-label=\"La valeur des m\u00e9dicaments au Canada\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-232x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-232x300.jpg 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-790x1024.jpg 790w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-768x995.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-1186x1536.jpg 1186w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf-445x576.jpg 445w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_v2-fr_ca-pdf.jpg 1306w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Acc\u00e8s aux m\u00e9dicaments<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">28 septembre 2023<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/la-valeur-des-medicaments-au-canada\/\">La valeur des m\u00e9dicaments au Canada<\/a><\/h3>\t\t\t\n\t\t\t<p>Cette \u00e9tude examine et quantifie la valeur des traitements novateurs au Canada pour la vie des patients, le syst\u00e8me de sant\u00e9 et la soci\u00e9t\u00e9. Les \u00e9tudes de cas comprennent les traitements pour le virus du papillome humain, le m\u00e9lanome, la polyarthrite rhumato\u00efde et l\u2019h\u00e9patite C.<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/la-valeur-des-medicaments-au-canada\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/09\/6456_IMC_ValueofMedicines_EFPIA_casestudies_2023_fre_v1-1.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/elaboration-dune-approche-canadienne-de-gestion-du-lancement-pour-les-nouvelles-innovations-que-peut-apprendre-le-canada-de-leurope\/\" aria-label=\"\u00c9laboration d\u2019une approche canadienne de gestion du lancement pour les nouvelles innovations : que peut apprendre le Canada de l\u2019Europe?\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"200\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/999999999.20230516145525310.999999999.20230516145525310Os8LH-300x200.jpeg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/999999999.20230516145525310.999999999.20230516145525310Os8LH-300x200.jpeg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/999999999.20230516145525310.999999999.20230516145525310Os8LH.jpeg 612w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Acc\u00e8s aux m\u00e9dicaments<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">16 mai 2023<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/elaboration-dune-approche-canadienne-de-gestion-du-lancement-pour-les-nouvelles-innovations-que-peut-apprendre-le-canada-de-leurope\/\">\u00c9laboration d\u2019une approche canadienne de gestion du lancement pour les nouvelles innovations : que peut apprendre le Canada de l\u2019Europe?<\/a><\/h3>\t\t\t\n\t\t\t<p>De nombreux nouveaux traitements arrivant sur le march\u00e9 ne sont pas bien pris en compte par les approches traditionnelles de remboursement des m\u00e9dicaments actuellement utilis\u00e9es par les r\u00e9gimes publics du pays.<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/elaboration-dune-approche-canadienne-de-gestion-du-lancement-pour-les-nouvelles-innovations-que-peut-apprendre-le-canada-de-leurope\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/2023-CADTH-Poster-French-V3.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content -->\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color has-text-color wp-element-button\" href=\"\/resources\/all-resources\/?resource-category=submission-papers\">View all<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-padded no-margin has-light-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-theme-teal no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"wp-block-cover alignwide page-excerpt child-page card linked-card has-custom-content-position is-position-bottom-left no-margin\">\n    <span class=\"wp-block-cover__gradient-background has-background-dim has-background-dim-100 has-background-gradient\" style=\"background:linear-gradient(0deg,rgb(0,0,0) 0%,rgba(0,0,0,0.03) 100%)\"><\/span>\n        <img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-1024x683.jpg\" class=\"wp-block-cover__image-background wp-post-image\" alt=\"\" itemprop=\"image\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-1024x683.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-768x512.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-1536x1024.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-744x496.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero-800x534.jpg 800w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/pharma101-hero.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>    <div class=\"wp-block-cover__inner-container\">\n        <h2 class=\"h5 has-white-color\">Pharmaceutique\u00a0101<\/h2>\n        <div class=\"has-smaller-font-size has-white-color\"><p>Use this beginner\u2019s guide to understand the basics of how our industry works.<\/p>\n<\/div>\n\n        <div class=\"wp-block-buttons\">\n            <div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color\" href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/pharmaceutique-101\/\">En savoir plus<\/a><\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-padded no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div id=\"letters\" class=\"wp-block-group theme-green featured-section no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading is-style-eyebrow\">Lettres<\/h2>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group featured-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb\/\" aria-label=\"Lettre \u00e0 Dre M\u00e9lanie Bourassa Forcier, Pr\u00e9sidente par int\u00e9rim, Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-232x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-232x300.jpg 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-791x1024.jpg 791w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-116x150.jpg 116w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf.jpg 1088w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">28 novembre 2022<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb\/\">Lettre \u00e0 Dre M\u00e9lanie Bourassa Forcier, Pr\u00e9sidente par int\u00e9rim, Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/a><\/h3>\t\t\t\n\t\t\t\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221128_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb-2\/\" aria-label=\"Lettre \u00e0 Dre M\u00e9lanie Bourassa Forcier, Pr\u00e9sidente par int\u00e9rim, Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-232x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-232x300.jpg 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-791x1024.jpg 791w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf-116x150.jpg 116w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca-pdf.jpg 1088w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">18 novembre 2022<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb-2\/\">Lettre \u00e0 Dre M\u00e9lanie Bourassa Forcier, Pr\u00e9sidente par int\u00e9rim, Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/a><\/h3>\t\t\t\n\t\t\t\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-dre-melanie-bourassa-forcier-presidente-par-interim-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb-2\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2023\/05\/20221118_LTR_Dr.-Melanie-Bourassa-Forcier_PMPRB-fr_ca.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content --><article itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"resource\">\n\t<div class=\"wp-block-columns no-margin is-not-stacked-on-mobile alignfull\" style=\"height: 100%;gap:2.4rem\">\n\t\t<header class=\"wp-block-column no-margin\" style=\"flex-basis:33%\">\n\t\t\t<a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-lhonorable-jean-yves-duclos-c-p-depute\/\" aria-label=\"Lettre \u00e0 L\u2019honorable Jean-Yves Duclos, C.P., d\u00e9put\u00e9\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf-232x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf-232x300.jpg 232w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf-791x1024.jpg 791w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf-768x994.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf-445x576.jpg 445w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos-pdf.jpg 1088w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/>\t\t\t<\/a>\n\t\t<\/header>\n\t\t<div class=\"wp-block-column no-margin content\">\n            <div class=\"wp-block-group\" style=\"display: flex;flex-direction: column;justify-content: space-between;height: 100%;\"><p class=\"post-meta small\">\n            \t\t\t\t\n\t\t\t\t<span class=\"category\" itemprop=\"articleSection\">Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB)<\/span>\n                <span class=\"divider\">\u2022<\/span>\n\t\t\t\t                <span class=\"date\" itemprop=\"datePublished\">09 novembre 2022<\/span>\t\t\t\t\n\t\t\t<\/p>\n\t\t\t<div><h3 itemprop=\"headline\" class=\"h5\"><a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-lhonorable-jean-yves-duclos-c-p-depute\/\">Lettre \u00e0 L\u2019honorable Jean-Yves Duclos, C.P., d\u00e9put\u00e9<\/a><\/h3>\t\t\t\n\t\t\t<p>MNC demande la suspension du processus de consultation sur les Lignes directrices du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB).<\/p>\n\t\t\t<p class=\"read-more has-small-font-size\">\n                <a href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/ressources\/toutes-les-ressources\/lettre-a-lhonorable-jean-yves-duclos-c-p-depute\/\">En savoir plus<\/a>\n                \t                <span>|<\/span>\n\t                <a target=\"_blank\" href=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/11\/20221108_Lettre_Ministre_Duclos.pdf\">Vue<\/a>\n\t                        <\/p><\/div><\/div>\n\t\t<\/div>\n\t<\/div> <!-- .wp-block-columns -->\n<\/article>\t<!-- #post-content -->\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color has-text-color wp-element-button\" href=\"\/resources\/all-resources\/?resource-category=submission-papers\">View all<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull no-margin is-padded has-light-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-theme-green child-page-container no-margin\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"wp-block-cover alignwide page-excerpt child-page card linked-card has-custom-content-position is-position-bottom-left no-margin\">\n    <span class=\"wp-block-cover__gradient-background has-background-dim has-background-dim-100 has-background-gradient\" style=\"background:linear-gradient(0deg,rgb(0,0,0) 0%,rgba(0,0,0,0.03) 100%)\"><\/span>\n        <img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"684\" src=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-1024x684.jpg\" class=\"wp-block-cover__image-background wp-post-image\" alt=\"\" itemprop=\"image\" srcset=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-1024x684.jpg 1024w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-300x200.jpg 300w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-768x513.jpg 768w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-1536x1026.jpg 1536w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-744x497.jpg 744w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero-800x534.jpg 800w, https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/newsroom-hero.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>    <div class=\"wp-block-cover__inner-container\">\n        <h2 class=\"h5 has-white-color\">Actualit\u00e9s<\/h2>\n        <div class=\"has-smaller-font-size has-white-color\"><p>Communiqu\u00e9s Dans les actualit\u00e9s Histoires du patient Twitter Feed rejoindre la liste des m\u00e9dias Soyez le premier \u00e0 recevoir nos [&hellip;]<\/p>\n<\/div>\n\n        <div class=\"wp-block-buttons\">\n            <div class=\"wp-block-button\"><a class=\"wp-block-button__link has-black-color\" href=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/actualites\/\">En savoir plus<\/a><\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<\/div><\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nous nous engageons \u00e0 \u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. Nous nous associons entre autres avec des [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":13647,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"9178,9184,9192,9194,9196,9198","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-13873","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Repr\u00e9sentation - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repr\u00e9sentation - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Nous nous engageons \u00e0 \u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. Nous nous associons entre autres avec des [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-10T19:36:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/\",\"name\":\"Repr\u00e9sentation - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/advocacy-hero.jpg\",\"datePublished\":\"2022-05-12T17:41:33+00:00\",\"dateModified\":\"2023-11-10T19:36:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/advocacy-hero.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/advocacy-hero.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/representation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repr\u00e9sentation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.bcdn.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Repr\u00e9sentation - Innovative Medicines Canada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Repr\u00e9sentation - Innovative Medicines Canada","og_description":"Nous nous engageons \u00e0 \u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. Nous nous associons entre autres avec des [&hellip;]","og_url":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2023-11-10T19:36:04+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/","url":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/","name":"Repr\u00e9sentation - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg","datePublished":"2022-05-12T17:41:33+00:00","dateModified":"2023-11-10T19:36:04+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/#primaryimage","url":"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg","contentUrl":"https:\/\/innovativemedicines.bcdn.ca\/wp-content\/uploads\/2022\/06\/advocacy-hero.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/representation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.bcdn.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Repr\u00e9sentation"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.bcdn.ca\/fr\/#website","url":"https:\/\/innovativemedicines.bcdn.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.bcdn.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/pages\/13873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/comments?post=13873"}],"version-history":[{"count":0,"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/pages\/13873\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/media\/13647"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.bcdn.ca\/fr\/wp-json\/wp\/v2\/media?parent=13873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}